Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 696 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
8 Results
PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers
- Colorectal Cancer
- Sarcoma Cancers
- Stomach and Esophagus
- Kidney Cancer
- Head and Neck Cancers
- Liver Cancer
- Lung Cancer
- Gynecological Cancers
- Pancreatic Cancer
- Prostate Cancer
- Thyroid and Other Endocrine Cancers
- Breast Cancer
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)
- Prostate Cancer
- Gender:Male only
- Age:21 years and older
A Phase 1, Open-Label, Multicenter Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Prostate Cancer
PRISM: Patient Experiences with PET Imaging in Prostate Cancer
- Prostate Cancer
The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer
- Prostate Cancer
Promoting Equity through a Culturally-Tailored Prostate Cancer Genetics Video for African American Males for Impact Long-term - PREVAIL Study
- Prostate Cancer
A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-969 in Adult Subjects With Metastatic Castration-Resistant Prostate Cancer
- Prostate Cancer
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Prostate Cancer